TCT

the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock
Feature | Hemodynamic Support Devices | April 28, 2017 | Dave Fornell

Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment...

Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation | March 31, 2017

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side...

Videos | Stents Bioresorbable | March 30, 2017

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses...

microbleeds, brain bleeds caused by TAVR

An MRI brain scan showing multiple microbleeds in a transcatheter aortic valve replacement (TAVR) patient from the study.

Feature | Heart Valve Technology | March 23, 2017

March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic...

Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology | March 22, 2017

March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...

RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis

A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.

Feature | Heart Valve Technology | March 21, 2017

March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood...

BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell

 

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...

iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters | March 20, 2017

March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

interventional cardiology, cath lab videos
Feature | Cath Lab | March 07, 2017

Here is a compilation of some of DAIC's recent video coverage of new interventional cardiology device technologies...

Videos | Stents Bifurcation | March 06, 2017

The Tryton Side Branch Stent became the first bifurcation stent cleared by the FDA in March 2017. The stent is...

tryton side branch stent, dedicated coronary side branch stent

The Tryton Side Branch Stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

Technology | Stents Bifurcation | March 06, 2017

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton...

CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra...

Claret Medical Sentinel Cerebral Protection System (CPS), FDA, TAVR embolic protection, transcatheter aortic valve replacement (TAVR).
News | Heart Valve Technology | February 28, 2017

February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...

transradial approach, same-day cardiac procedures, radial access, $300 million annual savings, JACC Cardiovascular Interventions study
News | Radial Access | February 22, 2017

February 22, 2017 — If hospitals can perform more...

Overlay Init